Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

Jean-Marc Classe,Cécile Loaec,Pierre Gimbergues,S. Alran,C. Tunon-de-Lara,Pierre-François Dupré,Roman Rouzier,C. Faure,N. Paillocher,M.-P. Chauvet,G. Houvenaeghel,Marian Gutowski,P De Blay,Johan Verhaeghe,Emmanuel Barranger,Celine Lefebvre,C. Ngô,G. Ferron,C. Palpacuer,L. Campion

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

2019

Purpose GANEA2 study was designed to assess accuracy and safety of sentinel lymph node (SLN) after neo-adjuvant chemotherapy (NAC) in breast cancer patients.

Keywords:

Axillary Lymph Node Dissection
Cancer research
Breast cancer
Sentinel lymph node
Axillary Lymphadenectomy
Biopsy
Radiology
Chemotherapy
Medicine
in patient
breast tumor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations